[EN] QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE<br/>[FR] FRAGMENTS HETEROARYLE A SUBSTITUTION QUINUCLIDINE DESTINES AU TRAITEMENT DE MALADIES
申请人:UPJOHN CO
公开号:WO2002016355A2
公开(公告)日:2002-02-28
The invention provides compound of Formula (I): These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula (I) are useful in pharmaceuticals in which α7 is known to be involved.